Anders Castor

Senior Lecturer
More filtering options
  1. 2019
  2. Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia

    Minjun Yang, Vesterlund, M., Siavelis, I., Moura-Castro, L. H., Anders Castor, Thoas Fioretos, Jafari, R., Henrik Lilljebjörn, Odom, D. T., Linda Olsson, Naveen Ravi, Eleanor L. Woodward, Harewood, L., Lehtiö, J. & Kajsa Paulsson, 2019 Apr 3, In : Nature Communications. 10, 1, 1519.

    Research output: Contribution to journalArticle

  3. Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor

    Biondi, A., Cario, G., De Lorenzo, P., Anders Castor, Conter, V., Leoni, V., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., Attarbaschi, A., Li, C-K., Vora, A., Bradtke, J., Saha, V., Valsecchi, M. G. & Schrappe, M., 2019 Jan, In : Haematologica. 104, 1, p. e13-e16

    Research output: Contribution to journalArticle

  4. 2018
  5. Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

    Cazzaniga, G., de Lorenzo, P., Alten, J., Röttgers, S., Hancock, J., Saha, V., Castor, A., Madsen, H. O., Gandemer, V., Cavé, H., Leoni, V., Köhler, R., Ferrari, G. M., Bleckmann, K., Pieters, R., Van Der Velden, V., Stary, J., Zuna, J., Escherich, G., Stadt, U. Z. & 5 othersAricò, M., Conter, V., Schrappe, M., Valsecchi, M. G. & Biondi, A., 2018 Jan 1, In : Haematologica. 103, 1, p. 107-115 9 p.

    Research output: Contribution to journalArticle

  6. Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial

    Biondi, A., Gandemer, V., De Lorenzo, P., Cario, G., Campbell, M., Anders Castor, Pieters, R., Baruchel, A., Vora, A., Leoni, V., Stary, J., Escherich, G., Li, C. K., Cazzaniga, G., Cavé, H., Bradtke, J., Conter, V., Saha, V., Schrappe, M. & Grazia Valsecchi, M., 2018, In : The Lancet Haematology. 5, 12, p. e641-e652

    Research output: Contribution to journalArticle

  7. Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia

    Rebeqa Gunnarsson, Dilorenzo, S., Kristina B. Lundin-Ström, Linda Olsson, Biloglav, A., Henrik Lilljebjörn, Rissler, M., Wahlberg, P., Lundmark, A., Anders Castor, Behrendtz, M., Thoas Fioretos, Kajsa Paulsson, Isaksson, A. & Bertil Johansson, 2018, In : Leukemia. 32, 10, p. 2117-2125

    Research output: Contribution to journalArticle

  8. 2017
  9. Early presentation of osteonecrosis in acute lymphoblastic leukemia: Two children from the Nordic and Baltic cohort

    Mogensen, S. S., Harila-Saari, A., Frandsen, T. L., Lähteenmäki, P. M., Anders Castor, Kohonen, I., Schmiegelow, K. & Mäkitie, O., 2017, In : Pediatric Blood & Cancer. 64, 11, e26624.

    Research output: Contribution to journalArticle

  10. 2016
  11. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia

    Marincevic-Zuniga, Y., Zachariadis, V., Cavelier, L., Anders Castor, Barbany, G., Forestier, E., Fogelstrand, L., Heyman, M., Abrahamsson, J., Lönnerholm, G., Nordgren, A., Syvänen, A-C. & Nordlund, J., 2016 Jan, In : Haematologica. 101, 1, p. e20-e23

    Research output: Contribution to journalArticle

  12. Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.

    Tulstrup, M., Larsen, H. B., Anders Castor, Rossel, P., Grell, K., Heyman, M., Abrahamsson, J., Söderhäll, S., Åsberg, A., Jonsson, O. G., Vettenranta, K., Frandsen, T. L., Albertsen, B. K. & Schmiegelow, K., 2016, In : Pediatric Blood & Cancer. 63, 5, p. 865-871

    Research output: Contribution to journalArticle

  13. Support from healthcare services during transition to adulthood - Experiences of young adult survivors of pediatric cancer.

    Svedberg, P., Einberg, E-L., Wärnestål, P., Stigmar, J., Anders Castor, Enskär, K. & Nygren, J. M., 2016, In : European Journal of Oncology Nursing. 21, p. 105-112

    Research output: Contribution to journalArticle

  14. The ethics of palliative sedation in children

    Anders Castor, Linus Broström & Mats Johansson, 2016.

    Research output: Contribution to conferenceAbstract

  15. 2015
  16. Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.

    Safavi, S., Linda Olsson, Biloglav, A., Srinivas Veerla, Blendberg, M., Tayebwa, J., Behrendtz, M., Anders Castor, Markus Hansson, Bertil Johansson & Kajsa Paulsson, 2015, In : Oncotarget. 6, 40

    Research output: Contribution to journalArticle

  17. The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.

    Kajsa Paulsson, Henrik Lilljebjörn, Biloglav, A., Linda Olsson, Rissler, M., Anders Castor, Barbany, G., Fogelstrand, L., Nordgren, A., Sjögren, H., Thoas Fioretos & Bertil Johansson, 2015, In : Nature Genetics. 47, 6, p. 672-676

    Research output: Contribution to journalArticle

  18. 2014
  19. Comparison of MRD monitoring by IG/TR rearrangement and BCR/ABL1 transcript in PH+ pediatric acute lymphoblastic leukemia patients treated with imatinib in the EsPhALL study

    Cazzaniga, G., De Lorenzo, P., Castor, A., Madsen, H. O., Gandemer, V., Cavé, H., Pieters, R., Van Der Velden, V., Stary, J., Zuna, J., Escherich, G., Stadt, U. Z., Rottgers, S., Alten, J., Hancock, J., Ferrari, G., Arico, M., Saha, V., Schrappe, M., Valsecchi, M. G. & 1 othersBiondi, A., 2014 Dec 6, In : Blood. 124, 21

    Research output: Contribution to journalPublished meeting abstract

  20. Comprehensive genetic characterization of pediatric T-cell acute lymphoblastic leukemia

    Karrman, K., Anders Castor, Behrendtz, M., Forestier, E., Linda Olsson, Mats Ehinger, Biloglav, A., Thoas Fioretos, Kajsa Paulsson & Bertil Johansson, 2014 Dec 6, In : Blood. 124, 21, p. 1084

    Research output: Contribution to journalPublished meeting abstract

  21. A nordic platform for clinical ethics in pediatric oncology

    Pergert, P., Brøner, T., A. Castor, Tóroddsdóttir, S., Edslev, P. W., Glosli, H., Frøland Hauge, H., Lehtinen, S., Petersen, S. G. & Törnudd, L., 2014 Dec 1, In : Pediatric Blood & Cancer. 61, Suppl. S2, p. S363 1 p., EP-496.

    Research output: Contribution to journalPublished meeting abstract

  22. 2013
  23. Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia

    Lutz, C., Woll, P. S., Hall, G., Anders Castor, Dreau, H., Cazzaniga, G., Zuna, J., Jensen, C., Clark, S. A., Biondi, A., Mitchell, C., Ferry, H., Schuh, A., Buckle, V., Jacobsen, S-E. W. & Enver, T., 2013, In : Leukemia. 27, 5, p. 1204-1207

    Research output: Contribution to journalLetter

  24. 2012
  25. Barnet i sjukvården

    Anders Castor, 2012 Jan, Ställföreträdarskap i vård och omsorg . Broström, L. & Johansson, M. (eds.). Gleerups Utbildning AB, p. 113-124

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  26. Etikrådet vid Barn- och ungdomssjukhuset i Lund

    Anders Castor & Mats Johansson, 2012, Är goda råd dyra?. Region Skånes etiska råd, R. S. E. R. (ed.). Region Skåne, p. 9-20

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  27. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

    Biondi, A., Schrappe, M., De Lorenzo, P., Anders Castor, Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., Li, C-K., Vora, A., Arico, M., Roettgers, S., Saha, V. & Valsecchi, M. G., 2012, In : The Lancet Oncology. 13, 9, p. 936-945

    Research output: Contribution to journalArticle

  28. 2011
  29. Efficacy and safety of imatinib on top of BFM-like chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL). the EsPhALL study

    Biondi, A., Schrappe, M., De Lorenzo, P., Anders Castor, Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., Kong-Li, C., Vora, A. J., Lonnerholm, G., Arico, M., Harbott, J., Saha, V. & Valsecchi, M. G., 2011 Nov 18, In : Blood. 118, 21, Abstract 873.

    Research output: Contribution to journalPublished meeting abstract

  30. Experimental Stem-Cell Based Therapy in Pediatrics: A Fictional Case Study

    Kristina Hug & Anders Castor, 2011, Translational Stem Cell Research: Issues Beyond the Debate on the Moral Status of the Human Embryo. Hug, K. & Hermerén, G. (eds.). Humana Press, p. 151-164 (Stem Cell Biology and Regenerative Medicine).

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  31. Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.

    Frandsen, T. L., Abrahamsson, J., Lausen, B., Vettenranta, K., Heyman, M., Behrentz, M., Anders Castor, Wehner, P. S., Frost, B-M., Andersen, E. W. & Schmiegelow, K., 2011, In : British Journal of Haematology. 155, p. 244-247

    Research output: Contribution to journalArticle

  32. 2010
  33. Selective Persistence of Distinct Stem/B Leukaemic Stem Cells In Childhood Acute Lymphoblastic Leukaemia In Clinical Remission

    Lutz, C., Woll, P., Anders Castor, Ferry, H., Jensen, C., Green, J., Dreau, H., Lutteropp, M., Schuh, A., Hall, G., Mitchell, C., Zuna, J., Buckle, V., Jacobsen, S. E. W. & Enver, T., 2010, In : Blood. 116, 21, p. 670-670

    Research output: Contribution to journalPublished meeting abstract

  34. 2009
  35. High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle

    Tipping, A. J., Pina, C., Anders Castor, Hong, D., Rodrigues, N. P., Lazzari, L., May, G. E., Jacobsen, S. E. W. & Enver, T., 2009, In : Blood. 113, 12, p. 2661-2672

    Research output: Contribution to journalArticle

  36. Individualized 6-Mercaptopurine Increments During Consolidation Treatment Of Lower Risk Childhood All

    Frandsen, T., Abrahamsson, J., Lausen, B., Vettenranta, K., Heyman, M., Behrentz, M., Anders Castor & Schmiegelow, K., 2009, In : Pediatric Blood & Cancer. 53, 5, p. 726-727

    Research output: Contribution to journalPublished meeting abstract

  37. 2008
  38. Exit of pediatric pre-B acute lymphoblastic leukaemia cells from the bone marrow to the peripheral blood is not associated with cell maturation or alterations in gene expression.

    Hansson, F., Toporski, J., Månsson, R., Bertil Johansson, Norén-Nyström, U., Jacobsen, S. E. W., Thomas Wiebe, Larsson, M., Mikael Sigvardsson & Anders Castor, 2008, In : Molecular Cancer. 7, 67.

    Research output: Contribution to journalArticle

  39. Mycket svåra beslut

    Anders Castor & Nils-Eric Sahlin, 2008, Risk & Risici. Persson, J. & Sahlin, N-E. (eds.). Bokförlaget Nya Doxa, p. 231-248

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  40. Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis

    Buitenhuis, M., Verhagen, L. P., van Deutekom, H. W. M., Anders Castor, Verploegen, S., Koenderman, L., Jacobsen, S. E. W. & Coffer, P. J., 2008, In : Blood. 111, 1, p. 112-121

    Research output: Contribution to journalArticle

  41. Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia

    Lonnerholm, G., Frost, B-M., Abrahamsson, J., Behrendtz, M., Anders Castor, Forestier, E., Heyman, M., Uges, D. R. A. & de Graaf, S. S. N., 2008, In : British Journal of Haematology. 142, 4, p. 616-621

    Research output: Contribution to journalArticle

  42. 2007
  43. Stem and progenitor cell involvement in acute lymphoblastic leukemia

    Anders Castor, 2007, Hematopoietic stem cell lab Lund stem cell centre. 150 p.

    Research output: ThesisDoctoral Thesis (compilation)

  44. 2005
  45. Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2

    Buitenhuis, M., van Deutekom, H. W. M., Verhagen, L. P., Anders Castor, Jacobsen, S. E. W., Lammers, J. W. J., Koenderman, L. & Coffer, P. J., 2005, In : Blood. 105, 11, p. 4272-4281

    Research output: Contribution to journalArticle

  46. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.

    Anders Castor, Nilsson, L., Åstrand-Grundström, I., Buitenhuis, M., Ramirez, C., Anderson, K., Strömbeck, B., Garwicz, S., Békássy, A., Schmiegelow, K., Lausen, B., Hokland, P., Lehmann, S., Gunnar Juliusson, Bertil Johansson & Jacobsen, S. E. W., 2005, In : Nature Medicine. 11, 6, p. 630-637

    Research output: Contribution to journalArticle

  47. 2003
  48. Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents

    Frost, BM., Lonnerholm, G., Koopmans, P., Abrahamsson, J., Behrendtz, M., Anders Castor, Forestier, E., Uges, DRA. & de Graaf, SSN., 2003, In : Acta Pædiatrica. 92, 5, p. 551-557

    Research output: Contribution to journalArticle

  49. 2002
  50. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi-institutional collaborative study

    Frost, BM., Eksborg, S., Bjork, O., Abrahamsson, J., Behrendtz, M., Anders Castor, Forestier, E. & Lonnerholm, G., 2002, In : Medical and Pediatric Oncology. 38, 5, p. 329-337

    Research output: Contribution to journalArticle

  51. 2001
  52. Doxorubicin pharmacokinetics in children with acute lymphoblastic leukemia

    Frost, B. M., Eksborg, S., Bjork, O., Abrahamsson, J., Behrendtz, M., Anders Castor, Forestier, E. & Lonnerholm, G., 2001, In : Leukemia. 15, 3, p. 498

    Research output: Contribution to journalPublished meeting abstract